EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Levobupivacaine Administration Suppressed Cell Metabolism in Human Adenocarcinoma A549 Cells

Masae Iwasaki, Makiko Yamamoto iD, Masahiro Tomihari, Kaori Fujii, Masashi Ishikawa iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Masae Iwasaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo 113-8602, Tokyo, Japan. Hauptthemen laut MEDLINE: Levobupivacaine, Lung Neoplasms, Adenocarcinoma of Lung, Adenocarcinoma. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perioperative anesthesia might directly alter cancer cell biology. We investigated the effects of levobupivacaine treatment on lung adenocarcinoma cells. A549 cells were treated with levobupivacaine at concentrations of 0.1 mM and 0.5 mM for 2 h. Transfection with angiotensin-converting enzyme 2 (ACE2) small interfering RNA (siRNA) was performed 6 h before the levobupivacaine treatment. Cell proliferation was assessed using a cell counting kit 8 (CCK-8), and ATP synthesis was evaluated with the CellTiter-Glo® 2.0 assay at 0 and 24 h after anesthesia exposure. RT-PCR was performed to examine various biomarkers. The levobupivacaine treatment suppressed ATP synthesis without affecting cell proliferation. This was associated with the upregulation of ACE2 and the downregulation of pro-cancer biomarkers, including HIF-1α, MMP-9, and β-catenin. The anticancer effect of levobupivacaine was negated when ACE2 siRNA was introduced, and it was further suppressed when combined with levobupivacaine. The RT-PCR results indicated that the expressions of B-cell/CLL lymphoma 2 (BCL2) and wingless/integrated 1 (WNT1) were reduced after levobupivacaine treatment, but these effects were reversed with ACE2 siRNA induction. The administration of levobupivacaine suppressed A549 cell metabolism and downregulated HIF-1α, MMP-9, WNT1, EGFR, and BCL2 in an ACE2-dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevobupivacaineLung NeoplasmsAdenocarcinoma of LungAdenocarcinomaHumansA549 CellsCell ProliferationAngiotensin-Converting Enzyme 2Gene Expression Regulation, Neoplasticbeta CateninPeptidyl-Dipeptidase ARNA, Small InterferingHypoxia-Inducible Factor 1, alpha Subunit

Stichwörter der Autor:innen

ACE2HIF-1αMMP-9Wnt1 pathwaylevobupivacainelung adenocarcinoma

Substanzen

LevobupivacaineAngiotensin-Converting Enzyme 2ACE2 protein, humanbeta CateninPeptidyl-Dipeptidase ARNA, Small InterferingHypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo 113-8602, Tokyo, Japan.

ORCID-Profile: Makiko Yamamoto, Masashi Ishikawa

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Iwasaki, M., Yamamoto, M., Tomihari, M., Fujii, K., & Ishikawa, M. (2025). Levobupivacaine Administration Suppressed Cell Metabolism in Human Adenocarcinoma A549 Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210833

Vancouver

Iwasaki M, Yamamoto M, Tomihari M, Fujii K, Ishikawa M. Levobupivacaine Administration Suppressed Cell Metabolism in Human Adenocarcinoma A549 Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210833

BibTeX
@article{Iwasaki2025,
  author = {Iwasaki, Masae and Yamamoto, Makiko and Tomihari, Masahiro and Fujii, Kaori and Ishikawa, Masashi},
  title = {Levobupivacaine Administration Suppressed Cell Metabolism in Human Adenocarcinoma A549 Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210833}
}
Kostenlos starten →